Cefmetazole Resistance Mechanism for Escherichia Coli Including ESBL-Producing Strains

PURPOSE: Cefmetazole (CMZ), a cephamycin antibiotic, is primarily used as a definitive therapy for Extended Spectrum β-Lactamase (ESBL)-producing Escherichia coli infections. However, the mechanism of CMZ resistance in E. coli is still unknown. To elucidate the resistance mechanism and to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Ryota, Kawamura, Masato, Sato, Takumi, Fujimura, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553235/
https://www.ncbi.nlm.nih.gov/pubmed/36237294
http://dx.doi.org/10.2147/IDR.S382142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553235/
https://www.ncbi.nlm.nih.gov/pubmed/36237294
http://dx.doi.org/10.2147/IDR.S382142

Ejemplares similares